CRISPR-Based Diagnostics Market to Hit $12.09 Billion by 2033, Driven by Infectious Disease & Cancer Testing

CRISPR-Based Diagnostics Market size reached US$ 3.04 Billion in 2024 and is expected to reach US$ 12.09 Billion by 2033, growing at a CAGR of 16.7% during the forecast period 2025-2033.

The CRISPR-Based Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

📌 Access valuable insights with our sample report - (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/crispr-based-diagnostics-market?rk

☛ CRISPR-Based Diagnostics Market Forces Driving Future Growth

✔ The CRISPR-based diagnostics market is being strongly driven by the rising prevalence of infectious diseases and the growing demand for rapid, highly accurate testing solutions. As healthcare shifts toward personalized care, the adoption of precision medicine and customized diagnostics has further accelerated the use of CRISPR technologies. Additionally, robust research investments and collaborations between biotechnology companies, academic institutions, and healthcare organizations are fueling innovation and expanding the scope of CRISPR-based diagnostic applications. The expansion of point-of-care testing and the increasing demand for decentralized diagnostics also contribute to market growth, as these platforms allow for faster, more accessible results in both clinical and resource-limited settings.

✔ Despite these positive trends, the market faces significant restraints. High research and development costs, coupled with stringent regulatory challenges, remain major barriers to widespread clinical approval and adoption. Compared to established methods such as PCR, CRISPR diagnostic platforms still face limitations in commercialization and scalability. Furthermore, technical hurdles, including contamination risks and the lack of assay standardization, pose challenges for ensuring consistent, reliable results across different healthcare settings.

☛ CRISPR-Based Diagnostics Industry News:

✔ In January 2025, CrisprBits Private Limited inaugurated a state-of-the-art laboratory dedicated to advancing CRISPR-based diagnostic solutions. The new facility is focused on developing innovative diagnostics for rare diseases, including hospital-acquired infections and antimicrobial resistance, leveraging the precision and power of CRISPR gene editing technology to address critical gaps in current diagnostic capabilities.

✔ In August 2023, CrisprBits announced a strategic collaboration with Molbio Diagnostics to advance the integration of CRISPR into Point-of-Care (POC) testing. This partnership is designed to leverage the combined strengths and expertise of both companies to identify and capitalize on emerging market opportunities. By uniting CrisprBits' cutting-edge CRISPR capabilities with Molbio's proven diagnostic platforms, the collaboration aims to accelerate the development of rapid, accurate, and accessible POC diagnostic solutions.

☛ CRISPR-Based Diagnostics Market: Industry Giants and Emerging Leaders:

OraSure Technologies, Inc., Mammoth Biosciences, Inc., Integrated DNA Technologies, GenScript, among others.

Research Methodology

Our research methodology employs a dual approach, combining qualitative insights with rigorous quantitative analysis to provide comprehensive and reliable market intelligence. The process begins with thorough secondary research, drawing from trusted industry publications, proprietary databases, and credible market sources. This is further enhanced by focused primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/crispr-based-diagnostics-market

☛ Segment Covered in the CRISPR-Based Diagnostics Market:

✔ By Technique: Recombinase Polymerase Amplification (RPA), Loop-mediated Isothermal Amplification (LAMP), Others

✔ By Product: Kits, Buffer Solutions, Software, Others

✔ By Disease: Infectious Diseases, Bacterial Infectious Diseases, Parasitic Infectious Diseases, Viral Infections, Others, Non-Infectious Diseases, Cardiovascular Diseases, Genetic Disorders, Cancers, Others

✔ By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic and Research Institutes, Others

☛ This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Top-down and bottom-up approach for regional analysis

📌 Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=crispr-based-diagnostics-market

☛ Regional Analysis for CRISPR-Based Diagnostics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the CRISPR-Based Diagnostics Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global CRISPR-Based Diagnostics Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the CRISPR-Based Diagnostics Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.